Apical topography and modulation of ICAM-1 expression on activated endothelium.
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmUltrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study.Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium.Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Targeted delivery of therapeutics to endothelium.ICAM-1: isoforms and phenotypes.Targeting antioxidant and antithrombotic biotherapeutics to endothelium.Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.Molecular-genetic imaging of cancer.Beneficial Effects of Coenzyme Q10 Supplementation on Lipid Profile and Intereukin-6 and Intercellular Adhesion Molecule-1 Reduction, Preliminary Results of a Double-blind Trial in Acute Myocardial InfarctionStreptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.Nanotechnology in interventional cardiology.Vascular targeting of antithrombotic agents.Dynamic factors controlling targeting nanocarriers to vascular endothelium.Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.Targeted endothelial nanomedicine for common acute pathological conditions.Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.In vivo detection of vascular adhesion protein-1 in experimental inflammation.The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).
P2860
Q27026630-D7B3CCDD-CA66-49B3-A960-DDAE0266004FQ30303105-F36E3738-3D30-43A8-8ACC-2025CCFF6CB6Q30397684-29A18EF5-0544-4122-B48F-ABBF93F73C5AQ30466992-84E2E744-9B2B-4A6B-909F-B8661235FB28Q30475849-382A685D-3BFE-49B2-82D2-FFEC96107584Q34418742-50CECC6F-F034-44B5-AC5E-D03C96E4E771Q34935960-2D6C05E3-5752-42CE-84C8-CD54DD40C17EQ35001301-4DCFA6E9-C263-4044-9B17-8ABF39E871F7Q35116121-E29D92E9-2294-480F-9115-1FAD9D97CEDBQ35973462-98155A7D-4A48-435F-9ECB-534E221DC3F1Q37184666-2BA4C5EF-D9C2-4EA5-9871-50949614E2C1Q37835765-407EE220-B438-49B7-A6E7-44F386BAC9C3Q37900267-5A35930F-301F-463D-AFBE-317231BC5B7FQ37902114-9936EE69-70CA-4C22-BDBB-0661EC64D23FQ37980236-6D446B07-40EE-466B-ABAB-0053EC4E4A45Q38151092-D01968E2-2923-4C34-9607-B02510ED1FAEQ38598987-6D29B3D3-2990-4DAB-B0C1-974CB4D85723Q39642336-BE405B9F-0B93-482F-A11D-41A935B0FCEBQ42857010-845D1622-5559-4E98-9A37-C90CA17DFF7DQ47675852-619825A5-56B7-41EC-B2B4-9B0D4E7347F4
P2860
Apical topography and modulation of ICAM-1 expression on activated endothelium.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@ast
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@en
type
label
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@ast
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@en
prefLabel
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@ast
Apical topography and modulation of ICAM-1 expression on activated endothelium.
@en
P2093
P2860
P1476
Apical topography and modulation of ICAM-1 expression on activated endothelium
@en
P2093
A Almenar-Queralt
A Duperray
D C Altieri
P2860
P304
P407
P577
1995-11-01T00:00:00Z